Increased myositis and possible myocarditis in melanoma patients treated with immune checkpoint inhibitors in the COVID-19 era
Our study suggests an increase in prevalence of ICI-mediated muscle damage including myositis and myocarditis in the COVID-19 era. Differentiation of these patients and further risk stratification may allow for development of guidelines for nuanced management of this serious complication.
Authors
- T. Vincent
- Sarah Yentz (ORCID: https://orcid.org/0000-0003-1877-8876)
- Leslie A. Fecher (ORCID: https://orcid.org/0000-0002-6534-7457)
- Allison L Gradone
- Alexi L. Vasbinder (ORCID: https://orcid.org/0000-0002-1380-5364)
- Salim S. Hayek (ORCID: https://orcid.org/0000-0003-0180-349X)
- Christopher D. Lao
Institutions
- University of Wisconsin–Madison (US)
- Thomas Jefferson University (US)
- University of Michigan (US)
- Sidney Kimmel Cancer Center (US)
Publication Details
- Journal
- Cancer Immunology Immunotherapy
- Published
- 2024-10-05
- DOI
- https://doi.org/10.1007/s00262-024-03803-5
- Citations
- 3
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.85